Quick answers
- What is Phyrago?
- Phyrago is a brand name of Dasatinib, a prescription medicine. The FDA NDC Directory lists 6 Phyrago products in 6 strengths and forms.
- Who makes Phyrago?
- Handa Therap holds the FDA application for Phyrago (NDA216099, approved December 5, 2023).
- Is there a generic or store brand of Phyrago?
- Yes. The FDA NDC Directory lists 42 other products with the same active ingredients, strength and form as a Phyrago product, 36 of them generic. Ask your pharmacist whether one is right for you.
- Has Phyrago been recalled?
- No recall linked to Phyrago products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Phyrago is
Each Phyrago product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Dasatinib · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| dasatinib 100 mg tablet (oral) | Phyrago | 7 products, 7 companies | — |
| dasatinib 140 mg tablet (oral) | Phyrago | 7 products, 7 companies | — |
| dasatinib 20 mg tablet (oral) | Phyrago | 7 products, 7 companies | — |
| dasatinib 50 mg tablet (oral) | Phyrago | 7 products, 7 companies | — |
| dasatinib 70 mg tablet (oral) | Phyrago | 7 products, 7 companies | — |
| dasatinib 80 mg tablet (oral) | Phyrago | 7 products, 7 companies | — |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Dasatinib →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA216099 | Handa Therap | December 5, 2023 | 6 |
Companies that list Phyrago
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Phyrago products.
- Cycle Pharmaceuticals Ltd6 products
Recalls
No recall linked to Phyrago products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.